What is WAT stock price today?

Visit our real-time dashboard for the current WAT stock price and live market data.

Is WAT stock going up or down today?

WAT stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy WAT stock now?

The decision to buy WAT depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is WAT a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for WAT based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is WAT stock overvalued or undervalued?

WAT currently trades at a P/E ratio of 31.75, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if WAT is fairly priced.

What is WAT's P/E ratio?

WAT has a price-to-earnings (P/E) ratio of 31.75, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is WAT's market cap?

WAT (Waters Corporation) has a market capitalization of $20.84 billion, making it a mid-cap stock.

What is WAT's price to book ratio?

Price-to-book ratio for WAT is available on our dashboard along with other valuation metrics.

Does WAT pay dividends?

WAT does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is WAT's dividend yield?

WAT does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is WAT stock a good long-term investment?

WAT's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is WAT's revenue growth rate?

Revenue growth data for WAT is available on our dashboard with detailed financial statement analysis.

Profitability metrics for WAT are available on our dashboard with complete income statement analysis.

What are the risks of investing in WAT?

Key risks for WAT include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does WAT compare to its competitors?

Compare WAT to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize WAT's performance and positioning.

What is WAT's stock price target for 2026?

Visit our prediction page for AI-powered price targets for WAT with bull, base, and bear case scenarios.

What do analysts say about WAT?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for WAT. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is WAT's next earnings report?

WAT reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

WAT - Waters Corporation

NYSE * Healthcare * Diagnostics & Research

$0.00

+$0.00 (+0.00%)

About Waters Corporation

Waters Corporation (WAT) common stock

Price Chart

Loading chart...

WAT Key Statistics

Market Cap

$20.84B

P/E Ratio

31.75

How WAT Compares to Peers

WAT is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
WAT(This stock)	$20.84B	31.8	0%	0.0%	-
UNHUnitedHealth Group	$362.83B	30.1	0%	0.0%	vs UNH
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 14, 2026 at 3:24 AM EDT

Ready to invest in WAT?

Commission-free trading available. Affiliate links.

WAT Lician Score

10% confidence

6.0/10

Good

WAT has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates WATacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

WAT Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for WAT

Dashboard

Enter a ticker to analyze